Spire Wealth Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03K Sell
57
-73
-56% -$3.94K ﹤0.01% 1862
2026
Q1
$6.79K Sell
130
-4
-3% -$240 ﹤0.01% 1744
2025
Q4
$7.88K Buy
134
+2
+2% +$122 ﹤0.01% 1789
2025
Q3
$7.34K Buy
132
+6
+5% +$321 ﹤0.01% 1868
2025
Q2
$6.48K Buy
126
+43
+52% +$2.16K ﹤0.01% 1870
2025
Q1
$4.87K Sell
83
-26
-24% -$1.76K ﹤0.01% 2068
2024
Q4
$7.85K Buy
109
+2
+2% +$147 ﹤0.01% 1910
2024
Q3
$8.56K Sell
107
-41
-28% -$3.08K ﹤0.01% 1679
2024
Q2
$10.6K Sell
148
-29
-16% -$2.13K ﹤0.01% 1619
2024
Q1
$12.4K Sell
177
-58,995
-100% -$4.22M ﹤0.01% 1650
2023
Q4
$4.16M Buy
59,172
+59,017
+38,075% +$3.89M 0.14% 166
2023
Q3
$10.6K Sell
155
-36,414
-100% -$2.88M ﹤0.01% 1716
2023
Q2
$2.99M Buy
36,569
+411
+1% +$33K 0.11% 182
2023
Q1
$2.68M Buy
36,158
+35,995
+22,083% +$2.77M 0.1% 189
2022
Q4
$14K Buy
163
+15
+10% +$1.19K ﹤0.01% 1505
2022
Q3
$11K Hold
148
﹤0.01% 1549
2022
Q2
$13K Buy
148
+4
+3% +$375 ﹤0.01% 1839
2022
Q1
$16K Sell
144
-4
-3% -$413 ﹤0.01% 1895
2021
Q4
$19K Hold
148
﹤0.01% 2142
2021
Q3
$18K Hold
148
﹤0.01% 1909
2021
Q2
$17K Buy
148
+12
+9% +$1.26K ﹤0.01% 1952
2021
Q1
$13K Buy
+136
New +$12.4K ﹤0.01% 2341

Other funds holding TECH

Spire Wealth Management's TECH Position: Q2 2026 in Review

Spire Wealth Management reduced its Bio-Techne (TECH) stake by 56% in Q2 2026, selling an estimated $3.94K and leaving 57 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Spire Wealth Management first reported a position in TECH in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.16M in Q4 2023. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Spire Wealth Management held 57 shares of Bio-Techne worth $4.03K as of Q2 2026.
  • Spire Wealth Management sold 73 Bio-Techne shares in Q2 2026, an estimated $3.94K.
  • Bio-Techne made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1862 holding.
  • Spire Wealth Management first reported a position in Bio-Techne in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Bio-Techne position peaked at $4.16M in Q4 2023.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.